Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Myeloid 1

Conditions

Sarcoma 264Osteosarcoma 80Sarcoma, Ewing 50Neoplasms 43Melanoma 43Gastrointestinal Stromal Tumors 41Colorectal Neoplasms 39Breast Neoplasms 37Bone Neoplasms 36Rhabdomyosarcoma 35Neoplasm Metastasis 32Ovarian Neoplasms 31Neuroblastoma 30Pancreatic Neoplasms 29Stomach Neoplasms 27Dendritic Cell Sarcoma, Interdigitating 27Lung Neoplasms 26Liposarcoma 26Leiomyosarcoma 25Glioblastoma 23Uterine Cervical Neoplasms 22Sarcoma, Synovial 22Head and Neck Neoplasms 22Carcinoma, Non-Small-Cell Lung 22Esophageal Neoplasms 21Sarcoma, Kaposi 18Lymphoma 18Carcinoma, Hepatocellular 18Urinary Bladder Neoplasms 17Prostatic Neoplasms 17

Interventions

cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Xanthogranuloma, Juvenile × Sarcoma × Clear all
NCT04079179 2025-09-18

NACHO-COBI

Baylor College of Medicine

Phase 2 Recruiting
90 enrolled
MyeloidSarcoma

Histiocytosis, Langerhans-Cell, Xanthogranuloma, Juvenile, Histiocytosis, Sinus, Histiocytic Disorders, Malignant, Erdheim-Chester Disease, Histiocytic Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡